“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

In a recent study conducted by researchers from Hong Kong, evidence has emerged suggesting that your cholesterol medication ...

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

Summary: A new study finds that brain shrinkage in Alzheimer’s patients does not follow a uniform pattern. Researchers ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

“It’s truly exciting because this drug is the first treatment ever that shows a clear slowing of decline in Alzheimer’s disease. It targets and influences the underlying disease process of AD instead ...

An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

Lewy Body Dementia is progressive, and causes uncontrollable tremors, problems with memory, attention, and sleep.

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

Researchers suggest that the way Alzheimer's reshapes our brains is as unique as our fingerprints, challenging long-held ...